Early correction of cell cycle perturbations predicts the immunological response to therapy in HIV-infected patients

Mirko Paiardini, Barbara Cervasi, Domenico Galati, Sabrina Dominici, Helmut Albrecht, Alessandra Sfacteria, Mauro Magnani, Guido Silvestri, Giuseppe Piedimonte

Research output: Contribution to journalArticle

Abstract

Objective: To determine whether changes in the indices of HIV-associated cell cycle dysregulation (i.e., increased expression of cyclin B1 and abnormal nucleolar structure) may predict the level of immunological reconstitution in HIV-infected patients treated with highly active antiretroviral therapy (HAART). Methods: Cross-sectional and longitudinal analysis of viral load, CD4 T cell counts, cyclin B1 expression, and AgNOR number and area of distribution in 30 HIV-infected patients who were studied before and up to 6 months after initiation of HAART. Results: In HIV-infected individuals, the level of cell cycle dysregulation correlated with the type of response to HAART. While low levels of dysregulation were present in patients with complete (both virological and immunological) response to HAART, high levels were present in HAART-treated patients with limited CD4 T cell increases despite persistent viral suppression (immunological non-responders). Importantly, the level of correction of cell cycle dysregulation after 60 days of therapy predicted the level of immune reconstitution after 6 months. Conclusion: These observations suggest that correction of cell cycle dysregulation predicts a good immunological response to HAARTand that sequential analysis of cell cycle dysregulation might help to identify patients that could benefit from alternative, immune-based interventions in addition to standard HAART.

Original languageEnglish
Pages (from-to)393-402
Number of pages10
JournalAIDS (London, England)
Volume18
Issue number3
DOIs
Publication statusPublished - Feb 20 2004

Fingerprint

Highly Active Antiretroviral Therapy
Cell Cycle
HIV
Cyclin B1
Therapeutics
T-Lymphocytes
CD4 Lymphocyte Count
Viral Load
Cross-Sectional Studies

Keywords

  • Cell cycle
  • Cyclin B1
  • Highly active antiretroviral therapy
  • HIV
  • Immunological non responder

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Early correction of cell cycle perturbations predicts the immunological response to therapy in HIV-infected patients. / Paiardini, Mirko; Cervasi, Barbara; Galati, Domenico; Dominici, Sabrina; Albrecht, Helmut; Sfacteria, Alessandra; Magnani, Mauro; Silvestri, Guido; Piedimonte, Giuseppe.

In: AIDS (London, England), Vol. 18, No. 3, 20.02.2004, p. 393-402.

Research output: Contribution to journalArticle

Paiardini, M, Cervasi, B, Galati, D, Dominici, S, Albrecht, H, Sfacteria, A, Magnani, M, Silvestri, G & Piedimonte, G 2004, 'Early correction of cell cycle perturbations predicts the immunological response to therapy in HIV-infected patients', AIDS (London, England), vol. 18, no. 3, pp. 393-402. https://doi.org/10.1097/00002030-200402200-00004
Paiardini, Mirko ; Cervasi, Barbara ; Galati, Domenico ; Dominici, Sabrina ; Albrecht, Helmut ; Sfacteria, Alessandra ; Magnani, Mauro ; Silvestri, Guido ; Piedimonte, Giuseppe. / Early correction of cell cycle perturbations predicts the immunological response to therapy in HIV-infected patients. In: AIDS (London, England). 2004 ; Vol. 18, No. 3. pp. 393-402.
@article{b3b426c797244470bc33f53f4852ecd6,
title = "Early correction of cell cycle perturbations predicts the immunological response to therapy in HIV-infected patients",
abstract = "Objective: To determine whether changes in the indices of HIV-associated cell cycle dysregulation (i.e., increased expression of cyclin B1 and abnormal nucleolar structure) may predict the level of immunological reconstitution in HIV-infected patients treated with highly active antiretroviral therapy (HAART). Methods: Cross-sectional and longitudinal analysis of viral load, CD4 T cell counts, cyclin B1 expression, and AgNOR number and area of distribution in 30 HIV-infected patients who were studied before and up to 6 months after initiation of HAART. Results: In HIV-infected individuals, the level of cell cycle dysregulation correlated with the type of response to HAART. While low levels of dysregulation were present in patients with complete (both virological and immunological) response to HAART, high levels were present in HAART-treated patients with limited CD4 T cell increases despite persistent viral suppression (immunological non-responders). Importantly, the level of correction of cell cycle dysregulation after 60 days of therapy predicted the level of immune reconstitution after 6 months. Conclusion: These observations suggest that correction of cell cycle dysregulation predicts a good immunological response to HAARTand that sequential analysis of cell cycle dysregulation might help to identify patients that could benefit from alternative, immune-based interventions in addition to standard HAART.",
keywords = "Cell cycle, Cyclin B1, Highly active antiretroviral therapy, HIV, Immunological non responder",
author = "Mirko Paiardini and Barbara Cervasi and Domenico Galati and Sabrina Dominici and Helmut Albrecht and Alessandra Sfacteria and Mauro Magnani and Guido Silvestri and Giuseppe Piedimonte",
year = "2004",
month = "2",
day = "20",
doi = "10.1097/00002030-200402200-00004",
language = "English",
volume = "18",
pages = "393--402",
journal = "AIDS",
issn = "0269-9370",
publisher = "NLM (Medline)",
number = "3",

}

TY - JOUR

T1 - Early correction of cell cycle perturbations predicts the immunological response to therapy in HIV-infected patients

AU - Paiardini, Mirko

AU - Cervasi, Barbara

AU - Galati, Domenico

AU - Dominici, Sabrina

AU - Albrecht, Helmut

AU - Sfacteria, Alessandra

AU - Magnani, Mauro

AU - Silvestri, Guido

AU - Piedimonte, Giuseppe

PY - 2004/2/20

Y1 - 2004/2/20

N2 - Objective: To determine whether changes in the indices of HIV-associated cell cycle dysregulation (i.e., increased expression of cyclin B1 and abnormal nucleolar structure) may predict the level of immunological reconstitution in HIV-infected patients treated with highly active antiretroviral therapy (HAART). Methods: Cross-sectional and longitudinal analysis of viral load, CD4 T cell counts, cyclin B1 expression, and AgNOR number and area of distribution in 30 HIV-infected patients who were studied before and up to 6 months after initiation of HAART. Results: In HIV-infected individuals, the level of cell cycle dysregulation correlated with the type of response to HAART. While low levels of dysregulation were present in patients with complete (both virological and immunological) response to HAART, high levels were present in HAART-treated patients with limited CD4 T cell increases despite persistent viral suppression (immunological non-responders). Importantly, the level of correction of cell cycle dysregulation after 60 days of therapy predicted the level of immune reconstitution after 6 months. Conclusion: These observations suggest that correction of cell cycle dysregulation predicts a good immunological response to HAARTand that sequential analysis of cell cycle dysregulation might help to identify patients that could benefit from alternative, immune-based interventions in addition to standard HAART.

AB - Objective: To determine whether changes in the indices of HIV-associated cell cycle dysregulation (i.e., increased expression of cyclin B1 and abnormal nucleolar structure) may predict the level of immunological reconstitution in HIV-infected patients treated with highly active antiretroviral therapy (HAART). Methods: Cross-sectional and longitudinal analysis of viral load, CD4 T cell counts, cyclin B1 expression, and AgNOR number and area of distribution in 30 HIV-infected patients who were studied before and up to 6 months after initiation of HAART. Results: In HIV-infected individuals, the level of cell cycle dysregulation correlated with the type of response to HAART. While low levels of dysregulation were present in patients with complete (both virological and immunological) response to HAART, high levels were present in HAART-treated patients with limited CD4 T cell increases despite persistent viral suppression (immunological non-responders). Importantly, the level of correction of cell cycle dysregulation after 60 days of therapy predicted the level of immune reconstitution after 6 months. Conclusion: These observations suggest that correction of cell cycle dysregulation predicts a good immunological response to HAARTand that sequential analysis of cell cycle dysregulation might help to identify patients that could benefit from alternative, immune-based interventions in addition to standard HAART.

KW - Cell cycle

KW - Cyclin B1

KW - Highly active antiretroviral therapy

KW - HIV

KW - Immunological non responder

UR - http://www.scopus.com/inward/record.url?scp=1642362243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642362243&partnerID=8YFLogxK

U2 - 10.1097/00002030-200402200-00004

DO - 10.1097/00002030-200402200-00004

M3 - Article

C2 - 15090790

AN - SCOPUS:1642362243

VL - 18

SP - 393

EP - 402

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 3

ER -